nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—TOP2A—Gastric Cancer Network 2—CACYBP—coronary artery disease	0.0136	0.213	CbGpPWpGaD
Valrubicin—Doxorubicin—RALBP1—coronary artery disease	0.00963	0.552	CrCbGaD
Valrubicin—TOP2A—Fluvastatin—Pitavastatin—coronary artery disease	0.00445	0.193	CbGdCrCtD
Valrubicin—Doxorubicin—NOS3—coronary artery disease	0.00397	0.228	CrCbGaD
Valrubicin—TOP2A—Fluvastatin—Rosuvastatin—coronary artery disease	0.00396	0.172	CbGdCrCtD
Valrubicin—Doxorubicin—NOS2—coronary artery disease	0.00383	0.22	CrCbGaD
Valrubicin—TOP2A—Simvastatin—Lovastatin—coronary artery disease	0.00379	0.165	CbGdCrCtD
Valrubicin—TOP2A—Simvastatin—Pravastatin—coronary artery disease	0.00379	0.165	CbGdCrCtD
Valrubicin—TOP2A—Fluvastatin—Atorvastatin—coronary artery disease	0.00337	0.146	CbGdCrCtD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ITGA3—coronary artery disease	0.003	0.0471	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CEBPD—coronary artery disease	0.00273	0.0429	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—GPX2—coronary artery disease	0.00244	0.0382	CbGpPWpGaD
Valrubicin—TOP2A—Alprenolol—Penbutolol—coronary artery disease	0.00217	0.0942	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—RAI1—coronary artery disease	0.00196	0.0308	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—coronary artery disease	0.00185	0.029	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—coronary artery disease	0.00151	0.0238	CbGpPWpGaD
Valrubicin—TOP2A—Methyltestosterone—Eplerenone—coronary artery disease	0.00151	0.0655	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—BHLHE40—coronary artery disease	0.00133	0.0208	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—ID3—coronary artery disease	0.00126	0.0199	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CREM—coronary artery disease	0.00121	0.019	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IL1A—coronary artery disease	0.00115	0.0181	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—coronary artery disease	0.00107	0.0169	CbGpPWpGaD
Valrubicin—Musculoskeletal discomfort—Captopril—coronary artery disease	0.00106	0.00118	CcSEcCtD
Valrubicin—Pruritus—Clopidogrel—coronary artery disease	0.00106	0.00118	CcSEcCtD
Valrubicin—Pruritus—Lovastatin—coronary artery disease	0.00105	0.00117	CcSEcCtD
Valrubicin—Asthenia—Ezetimibe—coronary artery disease	0.00104	0.00117	CcSEcCtD
Valrubicin—Gastrointestinal pain—Niacin—coronary artery disease	0.00104	0.00116	CcSEcCtD
Valrubicin—Nausea—Rosuvastatin—coronary artery disease	0.00104	0.00116	CcSEcCtD
Valrubicin—Diarrhoea—Fenofibrate—coronary artery disease	0.00104	0.00116	CcSEcCtD
Valrubicin—Abdominal pain—Valsartan—coronary artery disease	0.00104	0.00116	CcSEcCtD
Valrubicin—Feeling abnormal—Pravastatin—coronary artery disease	0.00103	0.00115	CcSEcCtD
Valrubicin—Ill-defined disorder—Ramipril—coronary artery disease	0.00103	0.00115	CcSEcCtD
Valrubicin—Abdominal pain—Olmesartan—coronary artery disease	0.00103	0.00115	CcSEcCtD
Valrubicin—Body temperature increased—Olmesartan—coronary artery disease	0.00103	0.00115	CcSEcCtD
Valrubicin—Pruritus—Ezetimibe—coronary artery disease	0.00103	0.00115	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.00103	0.00115	CcSEcCtD
Valrubicin—Gastrointestinal pain—Pravastatin—coronary artery disease	0.00103	0.00115	CcSEcCtD
Valrubicin—Diarrhoea—Clopidogrel—coronary artery disease	0.00102	0.00114	CcSEcCtD
Valrubicin—Asthenia—Eplerenone—coronary artery disease	0.00102	0.00114	CcSEcCtD
Valrubicin—Diarrhoea—Lovastatin—coronary artery disease	0.00102	0.00113	CcSEcCtD
Valrubicin—Nausea—Acetylsalicylic acid—coronary artery disease	0.00101	0.00113	CcSEcCtD
Valrubicin—Pruritus—Eplerenone—coronary artery disease	0.00101	0.00112	CcSEcCtD
Valrubicin—Abdominal pain—Niacin—coronary artery disease	0.00101	0.00112	CcSEcCtD
Valrubicin—Body temperature increased—Niacin—coronary artery disease	0.00101	0.00112	CcSEcCtD
Valrubicin—Dizziness—Fenofibrate—coronary artery disease	0.001	0.00112	CcSEcCtD
Valrubicin—Malaise—Ramipril—coronary artery disease	0.001	0.00112	CcSEcCtD
Valrubicin—Feeling abnormal—Trandolapril—coronary artery disease	0.001	0.00112	CcSEcCtD
Valrubicin—Feeling abnormal—Enalapril—coronary artery disease	0.001	0.00112	CcSEcCtD
Valrubicin—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000996	0.00111	CcSEcCtD
Valrubicin—Asthenia—Simvastatin—coronary artery disease	0.000996	0.00111	CcSEcCtD
Valrubicin—Diarrhoea—Ezetimibe—coronary artery disease	0.000996	0.00111	CcSEcCtD
Valrubicin—Flatulence—Lisinopril—coronary artery disease	0.000995	0.00111	CcSEcCtD
Valrubicin—Gastrointestinal pain—Enalapril—coronary artery disease	0.000992	0.00111	CcSEcCtD
Valrubicin—Abdominal pain—Pravastatin—coronary artery disease	0.000992	0.00111	CcSEcCtD
Valrubicin—Body temperature increased—Pravastatin—coronary artery disease	0.000992	0.00111	CcSEcCtD
Valrubicin—Dizziness—Clopidogrel—coronary artery disease	0.000988	0.0011	CcSEcCtD
Valrubicin—Feeling abnormal—Telmisartan—coronary artery disease	0.000986	0.0011	CcSEcCtD
Valrubicin—Pruritus—Simvastatin—coronary artery disease	0.000982	0.0011	CcSEcCtD
Valrubicin—Dizziness—Lovastatin—coronary artery disease	0.000981	0.0011	CcSEcCtD
Valrubicin—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000979	0.00109	CcSEcCtD
Valrubicin—Back pain—Lisinopril—coronary artery disease	0.000977	0.00109	CcSEcCtD
Valrubicin—Diarrhoea—Eplerenone—coronary artery disease	0.000975	0.00109	CcSEcCtD
Valrubicin—Vomiting—Fenofibrate—coronary artery disease	0.000966	0.00108	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000966	0.00108	CcSEcCtD
Valrubicin—Abdominal pain—Trandolapril—coronary artery disease	0.000963	0.00108	CcSEcCtD
Valrubicin—Body temperature increased—Trandolapril—coronary artery disease	0.000963	0.00108	CcSEcCtD
Valrubicin—Dizziness—Ezetimibe—coronary artery disease	0.000962	0.00107	CcSEcCtD
Valrubicin—Abdominal pain—Enalapril—coronary artery disease	0.000959	0.00107	CcSEcCtD
Valrubicin—Body temperature increased—Enalapril—coronary artery disease	0.000959	0.00107	CcSEcCtD
Valrubicin—Feeling abnormal—Captopril—coronary artery disease	0.000959	0.00107	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—NRIP1—coronary artery disease	0.000959	0.015	CbGpPWpGaD
Valrubicin—Rash—Fenofibrate—coronary artery disease	0.000958	0.00107	CcSEcCtD
Valrubicin—Dermatitis—Fenofibrate—coronary artery disease	0.000957	0.00107	CcSEcCtD
Valrubicin—Headache—Fenofibrate—coronary artery disease	0.000952	0.00106	CcSEcCtD
Valrubicin—Gastrointestinal pain—Captopril—coronary artery disease	0.000952	0.00106	CcSEcCtD
Valrubicin—Vomiting—Clopidogrel—coronary artery disease	0.00095	0.00106	CcSEcCtD
Valrubicin—Diarrhoea—Simvastatin—coronary artery disease	0.00095	0.00106	CcSEcCtD
Valrubicin—Chest pain—Ramipril—coronary artery disease	0.000948	0.00106	CcSEcCtD
Valrubicin—Myalgia—Ramipril—coronary artery disease	0.000948	0.00106	CcSEcCtD
Valrubicin—Abdominal pain—Telmisartan—coronary artery disease	0.000946	0.00106	CcSEcCtD
Valrubicin—Body temperature increased—Telmisartan—coronary artery disease	0.000946	0.00106	CcSEcCtD
Valrubicin—Vomiting—Lovastatin—coronary artery disease	0.000943	0.00105	CcSEcCtD
Valrubicin—Dizziness—Eplerenone—coronary artery disease	0.000942	0.00105	CcSEcCtD
Valrubicin—Rash—Clopidogrel—coronary artery disease	0.000942	0.00105	CcSEcCtD
Valrubicin—Dermatitis—Clopidogrel—coronary artery disease	0.000941	0.00105	CcSEcCtD
Valrubicin—Asthenia—Valsartan—coronary artery disease	0.00094	0.00105	CcSEcCtD
Valrubicin—Ill-defined disorder—Lisinopril—coronary artery disease	0.000937	0.00105	CcSEcCtD
Valrubicin—Discomfort—Ramipril—coronary artery disease	0.000937	0.00105	CcSEcCtD
Valrubicin—Asthenia—Olmesartan—coronary artery disease	0.000936	0.00104	CcSEcCtD
Valrubicin—Headache—Clopidogrel—coronary artery disease	0.000936	0.00104	CcSEcCtD
Valrubicin—Rash—Lovastatin—coronary artery disease	0.000935	0.00104	CcSEcCtD
Valrubicin—Dermatitis—Lovastatin—coronary artery disease	0.000935	0.00104	CcSEcCtD
Valrubicin—Anaemia—Lisinopril—coronary artery disease	0.000933	0.00104	CcSEcCtD
Valrubicin—Feeling abnormal—Perindopril—coronary artery disease	0.000931	0.00104	CcSEcCtD
Valrubicin—Headache—Lovastatin—coronary artery disease	0.000929	0.00104	CcSEcCtD
Valrubicin—Pruritus—Valsartan—coronary artery disease	0.000927	0.00104	CcSEcCtD
Valrubicin—Chest pain—Timolol—coronary artery disease	0.000927	0.00103	CcSEcCtD
Valrubicin—Myalgia—Timolol—coronary artery disease	0.000927	0.00103	CcSEcCtD
Valrubicin—Vomiting—Ezetimibe—coronary artery disease	0.000925	0.00103	CcSEcCtD
Valrubicin—Gastrointestinal pain—Perindopril—coronary artery disease	0.000924	0.00103	CcSEcCtD
Valrubicin—Pruritus—Olmesartan—coronary artery disease	0.000923	0.00103	CcSEcCtD
Valrubicin—Abdominal pain—Captopril—coronary artery disease	0.00092	0.00103	CcSEcCtD
Valrubicin—Body temperature increased—Captopril—coronary artery disease	0.00092	0.00103	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—UTS2R—coronary artery disease	0.000919	0.0144	CbGpPWpGaD
Valrubicin—Dizziness—Simvastatin—coronary artery disease	0.000918	0.00102	CcSEcCtD
Valrubicin—Rash—Ezetimibe—coronary artery disease	0.000918	0.00102	CcSEcCtD
Valrubicin—Dermatitis—Ezetimibe—coronary artery disease	0.000917	0.00102	CcSEcCtD
Valrubicin—Discomfort—Timolol—coronary artery disease	0.000916	0.00102	CcSEcCtD
Valrubicin—Asthenia—Niacin—coronary artery disease	0.000914	0.00102	CcSEcCtD
Valrubicin—Headache—Ezetimibe—coronary artery disease	0.000912	0.00102	CcSEcCtD
Valrubicin—Malaise—Lisinopril—coronary artery disease	0.000911	0.00102	CcSEcCtD
Valrubicin—Vomiting—Eplerenone—coronary artery disease	0.000906	0.00101	CcSEcCtD
Valrubicin—Feeling abnormal—Furosemide—coronary artery disease	0.000905	0.00101	CcSEcCtD
Valrubicin—Nausea—Fenofibrate—coronary artery disease	0.000903	0.00101	CcSEcCtD
Valrubicin—Pruritus—Niacin—coronary artery disease	0.000902	0.00101	CcSEcCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—HMGB1—coronary artery disease	0.000902	0.0142	CbGpPWpGaD
Valrubicin—Asthenia—Pravastatin—coronary artery disease	0.0009	0.001	CcSEcCtD
Valrubicin—Gastrointestinal pain—Furosemide—coronary artery disease	0.000898	0.001	CcSEcCtD
Valrubicin—Rash—Eplerenone—coronary artery disease	0.000898	0.001	CcSEcCtD
Valrubicin—Dermatitis—Eplerenone—coronary artery disease	0.000897	0.001	CcSEcCtD
Valrubicin—Diarrhoea—Valsartan—coronary artery disease	0.000897	0.001	CcSEcCtD
Valrubicin—Abdominal pain—Perindopril—coronary artery disease	0.000893	0.000997	CcSEcCtD
Valrubicin—Body temperature increased—Perindopril—coronary artery disease	0.000893	0.000997	CcSEcCtD
Valrubicin—Diarrhoea—Olmesartan—coronary artery disease	0.000892	0.000996	CcSEcCtD
Valrubicin—Headache—Eplerenone—coronary artery disease	0.000892	0.000996	CcSEcCtD
Valrubicin—Pruritus—Pravastatin—coronary artery disease	0.000888	0.000991	CcSEcCtD
Valrubicin—Nausea—Clopidogrel—coronary artery disease	0.000887	0.00099	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—ADORA1—coronary artery disease	0.000885	0.0139	CbGpPWpGaD
Valrubicin—Vomiting—Simvastatin—coronary artery disease	0.000882	0.000985	CcSEcCtD
Valrubicin—Nausea—Lovastatin—coronary artery disease	0.000881	0.000984	CcSEcCtD
Valrubicin—Rash—Simvastatin—coronary artery disease	0.000875	0.000977	CcSEcCtD
Valrubicin—Dermatitis—Simvastatin—coronary artery disease	0.000874	0.000976	CcSEcCtD
Valrubicin—Asthenia—Trandolapril—coronary artery disease	0.000874	0.000976	CcSEcCtD
Valrubicin—Feeling abnormal—Losartan—coronary artery disease	0.000873	0.000975	CcSEcCtD
Valrubicin—Diarrhoea—Niacin—coronary artery disease	0.000872	0.000973	CcSEcCtD
Valrubicin—Asthenia—Enalapril—coronary artery disease	0.000871	0.000972	CcSEcCtD
Valrubicin—Headache—Simvastatin—coronary artery disease	0.000869	0.00097	CcSEcCtD
Valrubicin—Body temperature increased—Furosemide—coronary artery disease	0.000868	0.000969	CcSEcCtD
Valrubicin—Abdominal pain—Furosemide—coronary artery disease	0.000868	0.000969	CcSEcCtD
Valrubicin—Gastrointestinal pain—Losartan—coronary artery disease	0.000867	0.000967	CcSEcCtD
Valrubicin—Dizziness—Valsartan—coronary artery disease	0.000867	0.000967	CcSEcCtD
Valrubicin—Nausea—Ezetimibe—coronary artery disease	0.000864	0.000965	CcSEcCtD
Valrubicin—Dizziness—Olmesartan—coronary artery disease	0.000862	0.000963	CcSEcCtD
Valrubicin—Pruritus—Trandolapril—coronary artery disease	0.000862	0.000962	CcSEcCtD
Valrubicin—Chest pain—Lisinopril—coronary artery disease	0.00086	0.00096	CcSEcCtD
Valrubicin—Myalgia—Lisinopril—coronary artery disease	0.00086	0.00096	CcSEcCtD
Valrubicin—Asthenia—Telmisartan—coronary artery disease	0.000859	0.000959	CcSEcCtD
Valrubicin—Pruritus—Enalapril—coronary artery disease	0.000859	0.000958	CcSEcCtD
Valrubicin—Diarrhoea—Pravastatin—coronary artery disease	0.000858	0.000958	CcSEcCtD
Valrubicin—Discomfort—Lisinopril—coronary artery disease	0.00085	0.000948	CcSEcCtD
Valrubicin—Pruritus—Telmisartan—coronary artery disease	0.000847	0.000945	CcSEcCtD
Valrubicin—Nausea—Eplerenone—coronary artery disease	0.000846	0.000944	CcSEcCtD
Valrubicin—Dizziness—Niacin—coronary artery disease	0.000843	0.000941	CcSEcCtD
Valrubicin—Abdominal pain—Losartan—coronary artery disease	0.000838	0.000935	CcSEcCtD
Valrubicin—Body temperature increased—Losartan—coronary artery disease	0.000838	0.000935	CcSEcCtD
Valrubicin—Asthenia—Captopril—coronary artery disease	0.000835	0.000932	CcSEcCtD
Valrubicin—Diarrhoea—Trandolapril—coronary artery disease	0.000834	0.000931	CcSEcCtD
Valrubicin—Vomiting—Valsartan—coronary artery disease	0.000833	0.00093	CcSEcCtD
Valrubicin—Diarrhoea—Enalapril—coronary artery disease	0.00083	0.000927	CcSEcCtD
Valrubicin—Dizziness—Pravastatin—coronary artery disease	0.00083	0.000926	CcSEcCtD
Valrubicin—Vomiting—Olmesartan—coronary artery disease	0.000829	0.000926	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000828	0.000924	CcSEcCtD
Valrubicin—Rash—Valsartan—coronary artery disease	0.000826	0.000922	CcSEcCtD
Valrubicin—Dermatitis—Valsartan—coronary artery disease	0.000826	0.000922	CcSEcCtD
Valrubicin—Nausea—Simvastatin—coronary artery disease	0.000824	0.00092	CcSEcCtD
Valrubicin—Pruritus—Captopril—coronary artery disease	0.000823	0.000919	CcSEcCtD
Valrubicin—Rash—Olmesartan—coronary artery disease	0.000822	0.000918	CcSEcCtD
Valrubicin—Dermatitis—Olmesartan—coronary artery disease	0.000822	0.000917	CcSEcCtD
Valrubicin—Headache—Valsartan—coronary artery disease	0.000821	0.000916	CcSEcCtD
Valrubicin—Diarrhoea—Telmisartan—coronary artery disease	0.000819	0.000914	CcSEcCtD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—GSK3B—coronary artery disease	0.000818	0.0128	CbGpPWpGaD
Valrubicin—Headache—Olmesartan—coronary artery disease	0.000817	0.000912	CcSEcCtD
Valrubicin—Asthenia—Perindopril—coronary artery disease	0.000811	0.000905	CcSEcCtD
Valrubicin—Vomiting—Niacin—coronary artery disease	0.00081	0.000904	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000809	0.000904	CcSEcCtD
Valrubicin—Dizziness—Trandolapril—coronary artery disease	0.000806	0.000899	CcSEcCtD
Valrubicin—Rash—Niacin—coronary artery disease	0.000803	0.000897	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—ARNTL—coronary artery disease	0.000803	0.0126	CbGpPWpGaD
Valrubicin—Dermatitis—Niacin—coronary artery disease	0.000803	0.000896	CcSEcCtD
Valrubicin—Dizziness—Enalapril—coronary artery disease	0.000802	0.000896	CcSEcCtD
Valrubicin—Pruritus—Perindopril—coronary artery disease	0.000799	0.000892	CcSEcCtD
Valrubicin—Headache—Niacin—coronary artery disease	0.000798	0.000891	CcSEcCtD
Valrubicin—Vomiting—Pravastatin—coronary artery disease	0.000798	0.00089	CcSEcCtD
Valrubicin—Diarrhoea—Captopril—coronary artery disease	0.000796	0.000889	CcSEcCtD
Valrubicin—Dizziness—Telmisartan—coronary artery disease	0.000791	0.000884	CcSEcCtD
Valrubicin—Rash—Pravastatin—coronary artery disease	0.000791	0.000883	CcSEcCtD
Valrubicin—Dermatitis—Pravastatin—coronary artery disease	0.00079	0.000882	CcSEcCtD
Valrubicin—Asthenia—Furosemide—coronary artery disease	0.000788	0.00088	CcSEcCtD
Valrubicin—Headache—Pravastatin—coronary artery disease	0.000786	0.000877	CcSEcCtD
Valrubicin—Nausea—Valsartan—coronary artery disease	0.000778	0.000869	CcSEcCtD
Valrubicin—Pruritus—Furosemide—coronary artery disease	0.000777	0.000868	CcSEcCtD
Valrubicin—Nausea—Olmesartan—coronary artery disease	0.000775	0.000865	CcSEcCtD
Valrubicin—Vomiting—Trandolapril—coronary artery disease	0.000775	0.000865	CcSEcCtD
Valrubicin—Diarrhoea—Perindopril—coronary artery disease	0.000773	0.000863	CcSEcCtD
Valrubicin—Vomiting—Enalapril—coronary artery disease	0.000772	0.000861	CcSEcCtD
Valrubicin—Dizziness—Captopril—coronary artery disease	0.00077	0.000859	CcSEcCtD
Valrubicin—Rash—Trandolapril—coronary artery disease	0.000768	0.000858	CcSEcCtD
Valrubicin—Dermatitis—Trandolapril—coronary artery disease	0.000767	0.000857	CcSEcCtD
Valrubicin—Rash—Enalapril—coronary artery disease	0.000765	0.000854	CcSEcCtD
Valrubicin—Dermatitis—Enalapril—coronary artery disease	0.000764	0.000853	CcSEcCtD
Valrubicin—Headache—Trandolapril—coronary artery disease	0.000763	0.000852	CcSEcCtD
Valrubicin—Vomiting—Telmisartan—coronary artery disease	0.000761	0.000849	CcSEcCtD
Valrubicin—Asthenia—Losartan—coronary artery disease	0.00076	0.000849	CcSEcCtD
Valrubicin—Headache—Enalapril—coronary artery disease	0.00076	0.000849	CcSEcCtD
Valrubicin—Nausea—Niacin—coronary artery disease	0.000757	0.000845	CcSEcCtD
Valrubicin—Rash—Telmisartan—coronary artery disease	0.000755	0.000842	CcSEcCtD
Valrubicin—Dermatitis—Telmisartan—coronary artery disease	0.000754	0.000842	CcSEcCtD
Valrubicin—Diarrhoea—Furosemide—coronary artery disease	0.000752	0.000839	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000751	0.000838	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—RAB1B—coronary artery disease	0.00075	0.0118	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—ENSA—coronary artery disease	0.00075	0.0118	CbGpPWpGaD
Valrubicin—Pruritus—Losartan—coronary artery disease	0.00075	0.000837	CcSEcCtD
Valrubicin—Headache—Telmisartan—coronary artery disease	0.00075	0.000837	CcSEcCtD
Valrubicin—Feeling abnormal—Ramipril—coronary artery disease	0.000749	0.000836	CcSEcCtD
Valrubicin—Dizziness—Perindopril—coronary artery disease	0.000747	0.000834	CcSEcCtD
Valrubicin—Nausea—Pravastatin—coronary artery disease	0.000745	0.000832	CcSEcCtD
Valrubicin—Gastrointestinal pain—Ramipril—coronary artery disease	0.000743	0.00083	CcSEcCtD
Valrubicin—Vomiting—Captopril—coronary artery disease	0.00074	0.000826	CcSEcCtD
Valrubicin—Rash—Captopril—coronary artery disease	0.000734	0.000819	CcSEcCtD
Valrubicin—Dermatitis—Captopril—coronary artery disease	0.000733	0.000818	CcSEcCtD
Valrubicin—Feeling abnormal—Timolol—coronary artery disease	0.000732	0.000817	CcSEcCtD
Valrubicin—Headache—Captopril—coronary artery disease	0.000729	0.000814	CcSEcCtD
Valrubicin—Gastrointestinal pain—Timolol—coronary artery disease	0.000727	0.000811	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—UTS2—coronary artery disease	0.000726	0.0114	CbGpPWpGaD
Valrubicin—Dizziness—Furosemide—coronary artery disease	0.000726	0.000811	CcSEcCtD
Valrubicin—Diarrhoea—Losartan—coronary artery disease	0.000725	0.00081	CcSEcCtD
Valrubicin—Nausea—Trandolapril—coronary artery disease	0.000724	0.000808	CcSEcCtD
Valrubicin—Nausea—Enalapril—coronary artery disease	0.000721	0.000805	CcSEcCtD
Valrubicin—Vomiting—Perindopril—coronary artery disease	0.000718	0.000802	CcSEcCtD
Valrubicin—Body temperature increased—Ramipril—coronary artery disease	0.000718	0.000802	CcSEcCtD
Valrubicin—Abdominal pain—Ramipril—coronary artery disease	0.000718	0.000802	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—PSMB5—coronary artery disease	0.000715	0.0112	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—PSMA6—coronary artery disease	0.000715	0.0112	CbGpPWpGaD
Valrubicin—Rash—Perindopril—coronary artery disease	0.000712	0.000795	CcSEcCtD
Valrubicin—Dermatitis—Perindopril—coronary artery disease	0.000712	0.000795	CcSEcCtD
Valrubicin—Nausea—Telmisartan—coronary artery disease	0.000711	0.000794	CcSEcCtD
Valrubicin—Headache—Perindopril—coronary artery disease	0.000708	0.00079	CcSEcCtD
Valrubicin—Abdominal pain—Timolol—coronary artery disease	0.000702	0.000784	CcSEcCtD
Valrubicin—Body temperature increased—Timolol—coronary artery disease	0.000702	0.000784	CcSEcCtD
Valrubicin—Dizziness—Losartan—coronary artery disease	0.000701	0.000782	CcSEcCtD
Valrubicin—Vomiting—Furosemide—coronary artery disease	0.000698	0.00078	CcSEcCtD
Valrubicin—Rash—Furosemide—coronary artery disease	0.000693	0.000773	CcSEcCtD
Valrubicin—Dermatitis—Furosemide—coronary artery disease	0.000692	0.000772	CcSEcCtD
Valrubicin—Nausea—Captopril—coronary artery disease	0.000691	0.000772	CcSEcCtD
Valrubicin—Headache—Furosemide—coronary artery disease	0.000688	0.000768	CcSEcCtD
Valrubicin—Feeling abnormal—Lisinopril—coronary artery disease	0.000679	0.000758	CcSEcCtD
Valrubicin—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000674	0.000752	CcSEcCtD
Valrubicin—Vomiting—Losartan—coronary artery disease	0.000674	0.000752	CcSEcCtD
Valrubicin—Nausea—Perindopril—coronary artery disease	0.000671	0.000749	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—RAB1B—coronary artery disease	0.000671	0.0105	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—ENSA—coronary artery disease	0.000671	0.0105	CbGpPWpGaD
Valrubicin—Rash—Losartan—coronary artery disease	0.000668	0.000746	CcSEcCtD
Valrubicin—Dermatitis—Losartan—coronary artery disease	0.000668	0.000745	CcSEcCtD
Valrubicin—Headache—Losartan—coronary artery disease	0.000664	0.000741	CcSEcCtD
Valrubicin—Nausea—Furosemide—coronary artery disease	0.000653	0.000728	CcSEcCtD
Valrubicin—Asthenia—Ramipril—coronary artery disease	0.000652	0.000728	CcSEcCtD
Valrubicin—Body temperature increased—Lisinopril—coronary artery disease	0.000652	0.000727	CcSEcCtD
Valrubicin—Abdominal pain—Lisinopril—coronary artery disease	0.000652	0.000727	CcSEcCtD
Valrubicin—Pruritus—Ramipril—coronary artery disease	0.000643	0.000718	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—coronary artery disease	0.000639	0.01	CbGpPWpGaD
Valrubicin—Asthenia—Timolol—coronary artery disease	0.000637	0.000712	CcSEcCtD
Valrubicin—Nausea—Losartan—coronary artery disease	0.00063	0.000703	CcSEcCtD
Valrubicin—Pruritus—Timolol—coronary artery disease	0.000629	0.000702	CcSEcCtD
Valrubicin—Diarrhoea—Ramipril—coronary artery disease	0.000622	0.000694	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—CST3—coronary artery disease	0.000613	0.00963	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CRK—coronary artery disease	0.000609	0.00956	CbGpPWpGaD
Valrubicin—Diarrhoea—Timolol—coronary artery disease	0.000608	0.000679	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—coronary artery disease	0.000601	0.00944	CbGpPWpGaD
Valrubicin—Dizziness—Ramipril—coronary artery disease	0.000601	0.000671	CcSEcCtD
Valrubicin—Asthenia—Lisinopril—coronary artery disease	0.000591	0.00066	CcSEcCtD
Valrubicin—Dizziness—Timolol—coronary artery disease	0.000588	0.000656	CcSEcCtD
Valrubicin—Pruritus—Lisinopril—coronary artery disease	0.000583	0.000651	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND2—coronary artery disease	0.00058	0.00911	CbGpPWpGaD
Valrubicin—Vomiting—Ramipril—coronary artery disease	0.000578	0.000645	CcSEcCtD
Valrubicin—Rash—Ramipril—coronary artery disease	0.000573	0.00064	CcSEcCtD
Valrubicin—Dermatitis—Ramipril—coronary artery disease	0.000573	0.000639	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—HSPA2—coronary artery disease	0.00057	0.00895	CbGpPWpGaD
Valrubicin—Headache—Ramipril—coronary artery disease	0.000569	0.000636	CcSEcCtD
Valrubicin—Vomiting—Timolol—coronary artery disease	0.000565	0.000631	CcSEcCtD
Valrubicin—Diarrhoea—Lisinopril—coronary artery disease	0.000564	0.00063	CcSEcCtD
Valrubicin—Rash—Timolol—coronary artery disease	0.00056	0.000625	CcSEcCtD
Valrubicin—Dermatitis—Timolol—coronary artery disease	0.00056	0.000625	CcSEcCtD
Valrubicin—Headache—Timolol—coronary artery disease	0.000557	0.000621	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—F7—coronary artery disease	0.000551	0.00864	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—THBS1—coronary artery disease	0.000547	0.00859	CbGpPWpGaD
Valrubicin—Dizziness—Lisinopril—coronary artery disease	0.000545	0.000608	CcSEcCtD
Valrubicin—Nausea—Ramipril—coronary artery disease	0.00054	0.000603	CcSEcCtD
Valrubicin—Nausea—Timolol—coronary artery disease	0.000528	0.000589	CcSEcCtD
Valrubicin—Vomiting—Lisinopril—coronary artery disease	0.000524	0.000585	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MAPRE1—coronary artery disease	0.00052	0.00816	CbGpPWpGaD
Valrubicin—Rash—Lisinopril—coronary artery disease	0.00052	0.00058	CcSEcCtD
Valrubicin—Dermatitis—Lisinopril—coronary artery disease	0.000519	0.00058	CcSEcCtD
Valrubicin—Headache—Lisinopril—coronary artery disease	0.000516	0.000576	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—TUBA1A—coronary artery disease	0.000495	0.00776	CbGpPWpGaD
Valrubicin—Nausea—Lisinopril—coronary artery disease	0.00049	0.000547	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—coronary artery disease	0.000488	0.00766	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—coronary artery disease	0.000484	0.0076	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—coronary artery disease	0.000484	0.0076	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—ADIPOQ—coronary artery disease	0.000475	0.00746	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MAPRE1—coronary artery disease	0.000465	0.0073	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—PPP2CA—coronary artery disease	0.000454	0.00713	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—HTR7—coronary artery disease	0.000453	0.00712	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TUBA1A—coronary artery disease	0.000442	0.00694	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT5A—coronary artery disease	0.000398	0.00624	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—coronary artery disease	0.00039	0.00612	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PPARGC1A—coronary artery disease	0.000387	0.00607	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—SIRT1—coronary artery disease	0.000374	0.00588	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—coronary artery disease	0.00037	0.0058	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—coronary artery disease	0.000364	0.00572	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—coronary artery disease	0.000357	0.00561	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—TMPO—coronary artery disease	0.000338	0.00531	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TMPO—coronary artery disease	0.000302	0.00475	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—coronary artery disease	0.000299	0.0047	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—LEP—coronary artery disease	0.000295	0.00463	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—coronary artery disease	0.000294	0.00461	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—coronary artery disease	0.000287	0.0045	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—NOS2—coronary artery disease	0.000275	0.00432	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—coronary artery disease	0.000264	0.00415	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PSMB5—coronary artery disease	0.000262	0.00412	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PSMA6—coronary artery disease	0.000262	0.00412	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PPARG—coronary artery disease	0.000257	0.00404	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—GSK3B—coronary artery disease	0.000256	0.00401	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—coronary artery disease	0.000254	0.00399	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CREB1—coronary artery disease	0.000254	0.00398	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—coronary artery disease	0.000251	0.00395	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PSMB5—coronary artery disease	0.000235	0.00368	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PSMA6—coronary artery disease	0.000235	0.00368	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—coronary artery disease	0.000234	0.00367	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—SERPINE1—coronary artery disease	0.000232	0.00364	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—coronary artery disease	0.000222	0.00348	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND2—coronary artery disease	0.000213	0.00334	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—coronary artery disease	0.000211	0.00331	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	0.000196	0.00307	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	0.00019	0.00299	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CCND2—coronary artery disease	0.00019	0.00299	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PPP2CA—coronary artery disease	0.000167	0.00262	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	0.000166	0.00261	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—coronary artery disease	0.000165	0.00258	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	0.000152	0.00239	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	0.000149	0.00235	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PPP2CA—coronary artery disease	0.000149	0.00234	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—BIRC5—coronary artery disease	0.000147	0.00231	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	0.000142	0.00223	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	0.00013	0.00204	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—IL6—coronary artery disease	0.00011	0.00173	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	0.000106	0.00166	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND1—coronary artery disease	9.22e-05	0.00145	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CCND1—coronary artery disease	8.24e-05	0.00129	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—coronary artery disease	7.23e-05	0.00114	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MAPK1—coronary artery disease	6.47e-05	0.00102	CbGpPWpGaD
